newsfilter
← Latest News
Business Wire·

Humanigen Announces Participation and Presentation at H.C. Wainwright Global Investment Conference

Humanigen, Inc. (NASDAQ:HGEN) ("Humanigen"), a late-stage clinical biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm' announced that Cameron Durrant, Chairman & CEO, will give a corporate pres